Apollomics (APLM) Shares Outstanding (Weighted Average) (2020 - 2025)
Apollomics (APLM) reported Shares Outstanding (Weighted Average) of $21.0 million for Q4 2025, up 233333233.33% quarter-over-quarter from $9.0 in Q4 2023.
Apollomics (APLM) Shares Outstanding (Weighted Average) (2020 - 2025) Analysis & Trends
Apollomics (APLM) has 5 years of Shares Outstanding (Weighted Average) data on file, last reported at $21.0 million in Q4 2025.
- Shares Outstanding (Weighted Average) for Q4 2025 came in at $21.0 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $21.0 million (changed N/A YoY), and the FY2025 annual result was $2.1 million, changed N/A from the prior year.
- Shares Outstanding (Weighted Average) grew to $21.0 million in Q4 2025 per APLM's latest filing, from $9.0 in the prior quarter.
- Over five years, Shares Outstanding (Weighted Average) peaked at $21.0 million in Q4 2025 and troughed at $3.0 in Q4 2022.
- A 4-year average of $5.9 million and a median of $281972.0 in 2021 frame the typical range for Shares Outstanding (Weighted Average).
- The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Weighted Average) sank 100.0% in 2022, then jumped 200.0% in 2023.
- A 4-year view of Shares Outstanding (Weighted Average) shows it stood at $281972.0 in 2021, then slumped by 100.0% to $3.0 in 2022, then jumped by 200.0% to $9.0 in 2023, then surged by 233333233.33% to $21.0 million in 2025.
- Business Quant data shows APLM's Shares Outstanding (Weighted Average) at $21.0 million in Q4 2025, $9.0 in Q4 2023, and $8.0 million in Q2 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 185,491.37 Bn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 400.00 Bn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 4,489.46 Bn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 100.00 Bn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 118.76 Bn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 417.01 Bn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 68.88 Bn |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 254.10 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 928.40 Mn |
| 10 | Apollomics | 294.00 Mn | 294.00 Mn | - | 21.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 21.00 Mn |
| Dec 31, 2023 | 9.00 |
| Jun 30, 2023 | 8.00 Mn |
| Dec 31, 2022 | 3.00 |
| Dec 31, 2021 | 281,972.00 |
| Dec 31, 2020 | 27.72 Mn |